Molecular
cytogenetics encompasses the combination of molecular biology
and cytogenetics. It enables to differentiate normal and cancer
causing cells. Molecular cytogenetics helps to study the structural
and functional organization of chromosomes and its nucleus, genomic
variations, expression and evolution, and chromosomal abnormalities
in medicinal and cancer-related genetics. It includes a series of
techniques that operate either with entire genome or with
specifically targeted DNA sequences. Fluorescence in situ
hybridization (FISH) is the most common molecular cytogenetic
technique in which the DNA probes are labeled with different colored
fluorescent tags to visualize one or more specific regions of the
genome.
Ask
For In-Depth Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/2491
Global
Molecular Cytogenetics Market: Drivers
High
prevalence of cancer and increasing application of molecular biology
in detection of inherited susceptibilities associated with cancer
development is expected to boost the molecular cytogenetics market
growth. For instance, according to Cancer Research UK, in 2018,
around 17 million new cases of cancer were diagnosed worldwide.
However, the use of alternative techniques such as PCR in situ for
fluorescent in situ hybridization technique may hamper growth of the
molecular cytogenetics market. PCR in situ is a new technique that is
capable of detecting very low nucleotide samples. The technique has
advantages such as higher speed and potential sensitivity over
conventional fluorescent in situ hybridization.
Global
Molecular Cytogenetics Market: Regional Analysis
On
the basis of region, the global molecular cytogenetics market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa. North America is expected to witness
significant growth in the molecular cytogenetics market over the
forecast period. The market growth is attributed to launch of new
products by key market players in the region. For instance, in
January 2019, Applied Spectral Imaging (ASI) — a California-based
provider of biomedical imaging analysis solutions — launched
updated products portfolio, which is designed to cater to increasing
demand of pathology and cytogenetic laboratories. The updated product
portfolio includes a new imaging methodology that is based on an
all-new algorithm coupled with advanced hardware components to
increase the scanning speed for fluorescence in situ hybridization
(FISH) imaging.
Global
Molecular Cytogenetics Market: Key Players
Key
players operating in the global molecular cytogenetics market
include,
1.
Affymetrix, Inc.
2.
Oxford Gene Technology
3.
Thermo Fisher Scientific
4.
Abbott Laboratories
5.
Agilent Technologies
6.
PerkinElmer
7.
Bio-Rad Laboratories
8.
Applied Spectral Imaging
9.
Quest Diagnostics
10.
Roche Diagnostics
11.
Danaher Corporation
12.
Sysmex Corporation
13.
Illumina, Inc.
Global
Molecular Cytogenetics Market: Taxonomy
By
Product Type: Reagents and Kits, Instruments, Consumables,
Software and Services
By
Technique:
Fluorescence
in situ Hybridization, Karyotyping, In Situ Hybridization
Comparative
Genomic Hybridization: Array-based Comparative Genomic Hybridization,
Standard Comparative Genomic Hybridization
Others
By
Application: Genetic Diagnostics, Cancer, Personalized Medicine,
Others
By
End User: Pharmaceutical & Biotechnology Companies, Clinical
and Diagnostic Laboratories, Research Institutes, Others
By
Region: North America, Europe, Asia Pacific, Latin America,
Middle East, Africa
Request
For Customization of This Exclusive Report @
https://www.coherentmarketinsights.com/insight/request-customization/2491
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
0 comments:
Post a Comment